l General Information |
Product Name | TMP-269 |
General description | TMP269 is a potent, selective class Iia HDAC inhibitor. |
Synonym | N-[[4-(4-phenyl-1,3-thiazol-2-yl)oxan-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3 yl]benzamide; TMP 269; TMP269 |
Purity | ≥99.0%(HPLC) | CAS Number | 1314890-29-3 |
Formula | C25H21F3N4O3S | Molecular Weight | 514.52 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Red solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Slightly soluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | TMP269 is a potent, selective class Iia HDAC inhibitor with IC50 of 157 nM, 97 nM, 43 nM and 23nM for HDAC4, HDAC5, HDAC7 and HDAC9, respectively. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
